Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Trading Update

10 Jan 2013 12:45

RNS Number : 2814V
Plant Health Care PLC
10 January 2013
Β 

ο»Ώ

Β 

10 January 2013

Β 

Plant Health Care plc

("Plant Health Care" or "the Company")

Β 

Trading Update

Β 

Β 

Plant Health Care plc, a leading provider of novel patent protected biological products to the global agriculture markets, provides the following post year-end update ahead of the announcement of its audited full year results for the year ended 31 December 2012 in March 2013.

Β 

The Board expects the results for the year to 31 December 2012 to show operating loss to be slightly better than expectations at approximately $6.5 million; and cash and short-term liquid investments better than expectations at $7.7 million. Revenue will be similar to last year at approximately $7.8 million.

Β 

A partnership agreement for foliar Harpin which was expected to be completed by the end of the year would have added significantly to the revenues for 2012. This agreement is now expected to be completed in the first quarter of 2013.

Β 

The Board continues to be excited about the ability of the Company to bring existing and new patented products to the market over the coming years. However, the precise timing of additional partnership agreements remains unpredictable.

Β 

Β 

~ ends ~

Β 

Β 

For further information, please contact:

Β 

Plant Health Care plc

John Brady, Chief Executive Officer

+1 603 525 3702

jabrady@planthealthcare.com

Stephen Weaver, Finance Director

+1 412 826 5488

sweaver@planthealthcare.com

Nomura Code Securities

+44 (0) 20 7776 1200

Chris Collins/ Clare Terlouw / Chris Golden

www.nomuracode.com

Powerscourt

+44 (0) 20 7250 1446

Paul Durman / Nick Dibden / Sophie Moate

paul.durman@powerscourt-group.com

nick.dibden@powerscourt-group.com

sophie.moate@powerscourt-group.com

Β 

Β 

About Plant Health Care plc: Plant Health Care plc ("Plant Health Care") is a leading provider of novel patent protected biological products to the global agriculture markets. The Company's ordinary shares have been quoted on the Alternative Investment Market ("AIM") of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") since February 2010 (ticker symbol/ mnemonic: PHC).

Β 

Further information is available at: www.planthealthcare.com.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTUROUROOAAAAR
Date   Source Headline
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:36 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSTrading Statement
11th Jan 20217:00 amRNSNotice of Trading Statement/Investor Presentation
5th Jan 20213:37 pmRNSBrazil approves PHC279 to Control Soybean Rust
11th Dec 20207:00 amRNSInvestor Presentation
9th Nov 20207:00 amRNSPlant Health Care and Wilbur-Ellis sign Agreement
7th Oct 20207:00 amRNSGrant of Options
6th Oct 20207:00 amRNSNew US PREtec Patents Issued
2nd Oct 20205:48 pmRNSSignificant Shareholder
25th Sep 20207:00 amRNSInvestor Presentation
23rd Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSInterim Report 30 June 2020
29th Jul 20207:00 amRNSTrading Statement
26th Jun 20204:41 pmRNSSecond Price Monitoring Extn
26th Jun 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20207:00 amRNSGrant of Options
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSPHC398 Approved by US EPA: PHC279 submitted to EPA
9th Jun 20207:00 amRNSGrant of options
2nd Jun 202011:13 amRNSResult of AGM
29th May 20207:00 amRNSHolding(s) in Company
27th May 20207:00 amRNSUpdate on PHC279 2019 Field Trials
6th May 20205:12 pmRNSAnnual Report & Accounts and AGM Notice Published
1st May 20203:21 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSResults for the year ended 31 December 2019
25th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20203:45 pmRNSHolding(s) in Company
19th Mar 20203:09 pmRNSHolding(s) in Company
16th Mar 202011:53 amRNSResults of General Meeting
11th Mar 20207:00 amRNSPHC279 Submitted for Regulatory Approval in Brazil
24th Feb 20209:18 amRNSResults of Placing and Subscription
24th Feb 20207:00 amRNSProposed Placing and Subscription
19th Feb 20207:00 amRNSBlock listing Interim Review
5th Feb 20207:00 amRNSEmploy California Registration
23rd Jan 20207:00 amRNSFirst US patent issues for PREtec peptide products
9th Jan 20207:00 amRNSBrazil Update
20th Dec 20197:00 amRNSHolding(s) in Company
19th Dec 20197:00 amRNSTrading Update
3rd Dec 20196:35 pmRNSHolding(s) in Company
22nd Nov 20192:11 pmRNSHolding(s) in Company
15th Nov 20193:42 pmRNSHolding(s) in Company
15th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSHolding(s) in Company
13th Nov 20194:40 pmRNSHolding(s) in Company
13th Nov 20194:08 pmRNSHolding(s) in Company
13th Nov 20193:59 pmRNSHolding(s) in Company
13th Nov 20193:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.